Schonfeld Strategic Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
PIP
KGAMU
WPM
BCM
Schonfeld Strategic Advisors's CDLX Position: Q2 2024 in Review
Schonfeld Strategic Advisors sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 3,860 shares — an estimated $559K sold.
Schonfeld Strategic Advisors first reported a position in CDLX in Q3 2018 and held it in 12 quarters. The position peaked at $2.92M in Q4 2020. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.
- Schonfeld Strategic Advisors reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 3,860 Cardlytics shares in Q2 2024, an estimated $559K.
- Schonfeld Strategic Advisors first reported a position in Cardlytics in Q3 2018 and held it in 12 quarters.
- Schonfeld Strategic Advisors's Cardlytics position peaked at $2.92M in Q4 2020.
- 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.